XML 35 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share Capital
12 Months Ended
Dec. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share Capital
12. Share Capital
The authorized share capital of the Company is as follows:
(a) Authorized Share Capital
Class A Shares
An unlimited number of subordinate voting shares, carrying one vote each, entitled to dividends equal to or greater than Class B shares, convertible at the option of the holder into one Class B share for each Class A share after the occurrence of certain events related to an offer to purchase all Class B shares.
Class B Shares
An unlimited number, carrying 20 votes each, convertible at any time at the option of the holder into one Class A share for each Class B share.
Preferred A Shares
An unlimited number, non-voting, issuable in series.
(b) Employee Stock Incentive Plan
On May 26, 2005, the Company’s shareholders approved the Company’s 2005 Stock Incentive Plan (the “2005 Incentive Plan”). The 2005 Incentive Plan authorizes the issuance of awards to employees, officers, directors and consultants of the Company with respect to 3,000,000 shares of MDC Partners’ Class A Subordinate Voting Shares or any other security into which such shares shall be exchanged. On June 1, 2007 and on June 2, 2009, the Company’s shareholders approved a total additional authorized Class A Shares of 3,750,000 to be added to the 2005 Incentive Plan for a total of 6,750,000 authorized Class A Shares. In addition, the plan was amended to allow shares under this plan to be used to satisfy share obligations under the Stock Appreciation Rights Plan (the “SARS” Plan”). On May 30, 2008, the Company’s shareholders approved the 2008 Key Partner Incentive Plan, which provides for the issuance of 900,000 Class A Shares. On June 1, 2011, the Company’s shareholders approved the 2011 Stock Incentive Plan, which provides for the issuance of up to 3,000,000 Class A Shares. In June 2013, the Company's shareholders approved an amendment to the SARS Plan to permit the Company to issue shares authorized under the SARS Plan to satisfy the grant and vesting awards under the 2011 Stock Incentive Plan. On June 1, 2016, the Company's shareholders approved the 2016 Stock Incentive Plan, which provides for the issuance of up to 1,500,000 Class A shares.
The following table summarizes information about time based and financial performance-based restricted stock and restricted stock unit awards granted under the 2005 Incentive Plan, 2008 Key Partner Incentive Plan, 2011 Stock Incentive Plan and 2016 Stock Incentive Plan:
 
Performance Based Awards
 
Time Based Awards
  
Shares
 
Weighted Average Grant Date Fair
Value
 
Shares
 
Weighted Average
Grant Date
Fair Value
Balance at December 31, 2013
462,666

 
$
9.79

 
913,788

 
$
12.54

Granted
120,578

 
25.09

 
293,705

 
21.99

Vested
(497,214
)
 
9.62

 
(264,478
)
 
10.88

Forfeited

 

 
(26,874
)
 
11.52

Balance at December 31, 2014
86,030

 
$
23.14

 
916,141

 
$
16.36

Granted
80,000

 
21.76

 
191,155

 
20.42

Vested
(68,067
)
 
25.21

 
(297,794
)
 
12.35

Forfeited

 

 
(35,000
)
 
21.69

Balance at December 31, 2015
97,963

 
$
19.61

 
774,502

 
$
18.71

Granted
10,000

 
14.00

 
392,500

 
12.53

Vested
(17,963
)
 
10.02

 
(380,367
)
 
16.02

Forfeited

 

 
(46,000
)
 
20.39

Balance at December 31, 2016
90,000

 
$
20.90

 
740,635

 
$
16.71


The total fair value of restricted stock and restricted stock unit awards, which vested during the years ended December 31, 2016, 2015 and 2014 was $6,272, $5,394 and $7,659, respectively. In connection with the vesting of these awards, the Company included in the taxable loss the amounts of $5,429, $4,678 and $11,874 in 2016, 2015 and 2014, respectively. At December 31, 2016, the weighted average remaining contractual life for performance based awards was 1.87 years and for time based awards was 1.65 years. At December 31, 2016, the fair value of all restricted stock and restricted stock unit awards was $5,441. The term of these awards is three years with vesting up to three years. At December 31, 2016, the unrecognized compensation expense for these awards was $7,105 and will be recognized through 2019. At December 31, 2016, there were 1,934,861 awards available to grant under all equity plans.
In addition, the Company awarded restricted stock and restricted stock unit awards of which 523,321 awarded shares were outstanding as of December 31, 2016. The vesting of these awards are contingent upon the Company meeting a cumulative three year earnings target and continued employment through the vesting date. Once the Company defines the earnings target, the grant date is established and the Company will record the compensation expense over the vesting period.
Prior to adoption of the 2005 Incentive Plan, the Company’s Prior 2003 Plan provided for grants of up to 2,836,179 options to employees, officers, directors and consultants of the Company. All the options granted were for a term of five years from the date of the grant and vest 20% on the date of grant and a further 20% on each anniversary date. In addition, the Company granted 802,440 options, on the privatization of Maxxcom, with a term of no more than 10 years from initial date of grant by Maxxcom and vest 20% in each of the first two years with the balance vesting on the third anniversary of the initial grant.
Information related to share option transactions grant under all plans over the past three years is summarized as follows:
 
Options Outstanding
 
Options Exercisable
 
Non Vested Options
  
Number Outstanding
 
Weighted Average
Price per
Share
 
Number Outstanding
 
Weighted Average
Price per
Share
 
 
Balance at December 31, 2013
112,500

 
$
6.03

 
112,500

 
$
6.03

 

Vested

 

 
  

 
  

 

Granted

 

 
  

 
  

 

Exercised

 

 
  

 
  

 

Expired and cancelled

 

 
  

 
  

 

Balance at December 31, 2014
112,500

 
$
5.70

 
112,500

 
$
5.70

 

Vested

 

 
  

 
  

 

Granted

 

 
  

 
  

 

Exercised
37,500

 
4.72

 
  

 
  

 

Expired and cancelled

 

 
  

 
  

 

Balance at December 31, 2015
75,000

 
$
5.28

 
75,000

 
$
5.28

 

Vested

 

 
  

 
  

 

Granted

 

 
  

 
  

 

Exercised
37,500

 
5.97

 
  

 
  

 

Expired and cancelled

 

 
  

 
  

 

Balance at December 31, 2016
37,500

 
$
5.83

 
37,500

 
$
5.83

 


At December 31, 2016, the intrinsic value of vested options and the intrinsic value of all options was $27. For options exercised during 2016, 2015 and 2014, the Company received cash proceeds of nil, $224 and nil, respectively. The Company did not receive any windfall tax benefits. The intrinsic value of options exercised during 2016, 2015 and 2014 was $471, $471 and nil, respectively. At December 31, 2016, the weighted average remaining contractual life of all outstanding options was 0.5 years and for all vested options was 0.5 years. At December 31, 2016, the unrecognized compensation expense of all options was nil.
Share options outstanding as of December 31, 2016 are summarized as follows:
 
 
Options Outstanding
 
Options Exercisable
Exercise Price
 
Outstanding Number
 
Weighted Average Contractual
Life
 
Weighted Average
Price per
Share
 
Exercisable Number
 
Weighted Average
Price per
Share
 
Weighted Average Contractual
Life
$5.83
 
37,500

 
0.50
 
$
5.83

 
37,500

 
$
5.83

 
0.50

The Company has reserved a total of 2,753,496 Class A shares in order to meet its obligations under various conversion rights, warrants and employee share related plans. At December 31, 2016 there were 781,135 shares available for future option and similar grants.